Translate the text from Welsh to English.



 
Mae’r cyllid hwn yn dangos bod Llywodraeth Cymru yn parhau i fuddsoddi er mwyn sicrhau bod pob Bwrdd ac Ymddiriedolaeth Iechyd trwy Gymru mewn sefyllfa gref i gynnal gwaith ymchwil, ac er mwyn sicrhau bod cleifion yng Nghymru yn cael cyfle i gymryd rhan mewn treialon clinigol a rhaglenni byd\-eang i ddarganfod cyffuriau.

Y llynedd, cymerodd mwy na 17,000 o gleifion ran mewn bron 480 o astudiaethau ymchwil clinigol mewn amrywiaeth o feysydd yn ymwneud â chlefydau \- gan gynnwys dementia, strôc, canser, diabetes ac iechyd meddwl. Bydd hyn i gyd yn helpu i sicrhau bod Cymru mor gystadleuol ag y bo modd ar lefel ryngwladol fel cyrchfan ymchwil.  
  
Ymhlith yr enghreifftiau o waith ymchwil sy’n cael ei arwain yng Nghymru mae’r treial PARAMEDIC 2, a fu’n ymchwilio i ddarganfod a yw’r cyffur adrenalin yn gwneud lles neu’n gwneud niwed wrth drin ataliad y galon y tu allan i’r ysbyty. Bydd yr ymchwil hwn yn helpu i wella’r driniaeth i bobl sy’n cael ataliad calon, nid yn unig yng Nghymru ond ar draws y byd. Mae hynny yn ei dro yn gwneud Cymru’n wlad fwy cystadleuol yn y maes ymchwil yn rhyngwladol.  
  
Gwnaeth yr Ysgrifennydd Iechyd y cyhoeddiad wrth ymweld â’r Ganolfan Ymchwil ac Arloesi Clinigol ym Mwrdd Iechyd Prifysgol Aneurin Beran.  
  
Mae’r Ganolfan yn enghraifft o fuddsoddiad strategol gan Fwrdd Iechyd Prifysgol Aneurin Bevan, sy’n rhoi man canolog i ymchwilwyr a staff cyflenwi allu cymryd rhan mewn ymchwil sy’n torri tir newydd. Mae’r ganolfan wedi sicrhau hefyd bod cleifion yn gallu cael triniaeth yn nes at ble maen nhw’n byw.   
  
Wrth gyhoeddi’r cyllid, dywedodd Vaughan Gething:


> “Rydyn ni’n sylweddoli mor bwysig yw swyddogaeth ymchwil o ran gwella canlyniadau iechyd. Dyna pam mae Llywodraeth Cymru wedi neilltuo mwy na £21m fel rhan o becyn cymorth i gryfhau’r amgylchedd ymchwil yn y GIG yng Nghymru. 
> 
> “Mae cyfleusterau fel y Ganolfan Ymchwil ac Arloesi Clinigol ym Mwrdd Iechyd Prifysgol Aneurin Bevan yn chwarae rhan bwysig o ran cynyddu’r cyfle sydd ar gael i gleifion ymuno ag astudiaethau ymchwil cenedlaethol a rhyngwladol o ansawdd uchel, a hynny yn eu hardal eu hunain.
> 
> “Mae mwy a mwy o dystiolaeth ar gael bod amgylcheddau ymchwil yn arwain at ganlyniadau gwell i gleifion. Mae angen inni gefnogi ac annog cleifion, gofalwyr a staff i gymryd rhan lawn mewn gwaith ymchwil a sicrhau ei fod yn weithgarwch craidd o fewn y GIG.   
> 
> “Rydym am i Gymru fod yn un o’r llefydd mwyaf atyniadol yn y byd ar gyfer ymchwil academaidd a chlinigol. Fel rhan o’r pecyn hwn, rydym yn parhau i fuddsoddi’n helaeth mewn ymchwil Iechyd a Gofal Cymdeithasol, a fydd yn helpu i ddenu’r doniau gorau i Gymru.”

Dywedodd Prif Swyddog Meddygol Cymru, Dr Frank Atherton:  

> “Pan fydd ymchwilwyr yn mynd ati i ddarganfod a yw triniaeth yn gweithio, maen nhw’n edrych ar fwy o gleifion nag y bydd un meddyg unigol fyth yn eu trin. Y llynedd, dewisodd mwy na 17,000 o bobl yng Nghymru gymryd rhan mewn ymchwil glinigol. Y cyllid hwn yw’r cam cyntaf allweddol tuag at gasglu’r dystiolaeth sydd ei hangen arnom er mwyn ateb y cwestiynau sydd gennym am ystod eang o gyflyrau meddygol.   
> “Fe wyddom hefyd fod cleifion yn elwa ar ymchwil glinigol. Dyna pam mae cymryd rhan mewn astudiaeth ymchwil yn rhywbeth i’w groesawu yn aml, gan ei fod yn gallu rhoi dewis arall iddynt o ran eu triniaeth \- a hwnnw weithiau’n ddewis allweddol. Ond mae’n werth cofio nad oes raid ichi fod yn sâl i allu cymryd rhan a gwneud gwahaniaeth. Un o’r ffyrdd hawsaf o gymryd rhan mewn ymchwil a gofal iechyd yw trwy gofrestru gyda Doeth am Iechyd Cymru.”







Translation:


 
The Centre is an example of the strategic investment by Aneurin Bevan University Health Board, which provides a focal point for researchers and delivery staff to participate in ground breaking research. The centre has also ensured that patients can receive treatment closer to home.    
  
The Health Secretary made the announcement during a visit to the Clinical Research and Innovation Centre at Aneurin Bevan University Health Board.    
  
An example of research being led in Wales includes the PARAMEDIC 2 trial which looked at whether the drug adrenaline is helpful or harmful in the treatment of a cardiac arrest that occurs outside a hospital. This research will help to improve the treatment of people who have a cardiac arrest not just in Wales but across the world and in turn, maximises Wales’ international competitiveness in research.   
  
Last year, over 17,000 patients participated in almost 480 clinical research studies across a broad range of disease areas – including dementia, stroke, cancer, diabetes and mental health, all of which will help to maximise the international competitiveness of Wales as a destination for research.   

The funding demonstrates the continued investment being made by Welsh Government to ensure every Health Board and Trust across Wales is well placed to support a robust environment for research, and ensure patients in Wales have the opportunity to participate in clinical trials and global drug discovery programmes. 

Announcing the funding, Vaughan Gething said:


> “We recognise the significant role research plays in improving health outcomes, which is why the Welsh Government has committed more than £21m as part of a package of support to strengthen the research environment in the Welsh NHS. 
> 
> “Facilities such as the Clinical Research and Innovation Centre at Aneurin Bevan University Health Board play an important role in increasing research opportunities for patients to join national and international high quality research studies within their locality.
> 
> “There is a growing body of evidence that research environments lead to improved outcomes for patients. We need to support and encourage patients, carers and staff to fully embrace research and make it a core activity within the NHS.
> 
> “We want to make Wales one of the most attractive places in the World for academic and clinical research. As part of this package, we are continuing to invest significantly in Health and Social Care research which will help attract the best talent to Wales”.

Chief Medical Officer for Wales, Dr Frank Atherton said:  
  

> “When researchers look at whether a treatment works, they observe many more patients than a single doctor will ever treat. Last year more than 17,000 people in Wales chose to take part in clinical research. This funding is the crucial first step towards the evidence we need in order to answer the questions we have about a wide range of medical conditions. “We also know that patients benefit from clinical research, which is why involvement in a research study is often welcome as it can offer them a new, sometimes breakthrough, treatment option. But it’s worth remembering that you don’t have to be unwell to take part and make a difference. One of the easiest ways to get involved in health and social care research is by registering for HealthWise Wales.”